Retractable Technologies
About: Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.
Employees: 151
0
Funds holding %
of 7,372 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
4,655% more capital invested
Capital invested by funds: $1.81M [Q3] → $86.2M (+$84.3M) [Q4]
8.09% more ownership
Funds ownership: 7.86% [Q3] → 15.95% (+8.09%) [Q4]
0% more funds holding
Funds holding: 31 [Q3] → 31 (+0) [Q4]
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
60% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 10
Research analyst outlook
We haven’t received any recent analyst ratings for RVP.
Financial journalist opinion
Neutral
Business Wire
1 month ago
Retractable Technologies, Inc. Withdraws Complaint in United States Court of International Trade
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) (“RTI” or “Retractable”) has withdrawn its complaint in the United States Court of International Trade against the defendants involved in the issuance of a 100% tariff on syringes and needles imported from China. As a result, the case was dismissed effective January 8, 2025. Initial investigations into the matter convinced RTI management that although the tariffs were not properly implemented, there was no c.
Neutral
Business Wire
2 months ago
Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning October 1, 2024 through December 31, 2024. The dividends will be paid on January 20, 202.
Neutral
Business Wire
3 months ago
Retractable Technologies, Inc. Results for the Periods Ended September 30, 2024
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports total net sales of $10.3 million for the third quarter of 2024 and an operating loss of $5.1 million for the period, as compared to total net sales for the same period last year of $10.3 million and an operating loss of $936 thousand. For the first nine months of the year, net sales were $24.0 million and operating losses were $13.9 million as compared to 2023 net revenues of $29.3 million and operat.
Neutral
Business Wire
5 months ago
Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning July 1, 2024 through September 30, 2024. The dividends will be paid on October 21, 2024.
Neutral
Business Wire
5 months ago
Retractable Technologies, Inc. Files Complaint in United States Court of International Trade
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) announces that on September 26, 2024, it filed a complaint in the United States Court of International Trade against defendants involved in the issuance of a recent decision implementing a 100% tariff on syringes and needles imported from China, effective September 27, 2024. Such defendants include the United States of America, the Office of the United States Trade Representative, Trade Representative Kather.
Neutral
Business Wire
5 months ago
Tariffs Finalized on Chinese Imports
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) announces that on September 13, 2024, the Office of the United States Trade Representative (“USTR”) revealed final adjustments to tariffs placed on Chinese imported syringes and needles. Despite initially proposing a 50% rate, the USTR set the tariff at 100% effective September 27, 2024. Retractable's competitor, Becton, Dickinson and Company (“BD”), requested an increase to “the maximum tariff level availab.
Neutral
Business Wire
8 months ago
Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning April 1, 2024 through June 30, 2024. The dividends will be paid on July 22, 2024 to shar.
Neutral
Business Wire
9 months ago
Retractable Technologies, Inc. Results for the Period Ended March 31, 2024
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports total net sales of $7.6 million for the first three months of 2024 and an operating loss of nearly $3.0 million for the period, as compared to total net sales for the same period last year of $11.0 million and an operating loss of $2.7 million. The differences in the revenues and operating losses are largely due to the lack of syringe sales to the international market for COVID-19 vaccination efforts.
Neutral
Business Wire
11 months ago
Retractable Technologies, Inc. Reports Results for 2023
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports the following information relating to the year ended December 31, 2023. Further details concerning the results of operations as well as other matters are available in Retractable's Form 10-K filed on March 29, 2024 with the U.S. Securities and Exchange Commission. Our revenues for 2023 decreased 54.0% as domestic and international COVID-19 vaccination sales decreased. We had revenues of approximately.
Neutral
Business Wire
11 months ago
Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning January 1, 2024 through March 31, 2024. The dividends will be paid on April 22, 2024 to.
Charts implemented using Lightweight Charts™